Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease
Authors:
Open Access
- 2 February 2009
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 84 (4) , 231-233
Abstract
Baseline level of the cysteinyl leukotriene (CysLT), leukotriene E4 (LTE4), is associated with an increased pain rate in children and adults with sickle cell disease (SCD). To provide additional evidence for a role of CysLTs in the pathogenesis of vaso-occlusion, we tested the hypothesis that LTE4 levels will increase within an individual during painful episodes compared to baseline. In a cohort of 19 children and adults with SCD, median LTE4 levels increased from 82.36 pg/mg creatinine at baseline to 162.81 pg/mg creatinine during a painful episode (P < 0.001). These data further support a contribution of CysLTs to the process of vaso-occlusion. Am. J. Hematol., 2009.Keywords
This publication has 14 references indexed in Scilit:
- Urinary cysteinyl leukotriene E4 is associated with increased risk for pain and acute chest syndrome in adults with sickle cell diseaseAmerican Journal of Hematology, 2008
- Sibling history of asthma is a risk factor for pain in children with sickle cell anemiaAmerican Journal of Hematology, 2008
- Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell diseaseAmerican Journal of Hematology, 2008
- LeukotrienesNew England Journal of Medicine, 2007
- Measurement of Leukotrienes in HumansAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Peptido-Leukotrienes Are Potent Agonists of von Willebrand Factor Secretion and P-Selectin Surface Expression in Human Umbilical Vein Endothelial CellsCirculation, 1995
- Cysteinyl Leukotrienes in the Urine of Patients With Liver DiseasesHepatology, 1994
- Leukotriene E4 and granulocytic infiltration into asthmatic airwaysThe Lancet, 1993
- Pain in Sickle Cell DiseaseNew England Journal of Medicine, 1991
- Analysis of cysteinyl leukotrienes in human urine:enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome*European Journal of Clinical Investigation, 1989